Value investing message boards image Log on |  Join ($$) Stock market forums image VF "How To" Guide        Welcome, guest! Learn about guest access                       
ValueForum.com Home
• Related Discussion Forum Messages
As a ValueForum member, this section would contain LJPC message board posts where the ticker symbol LJPC has been mentioned by ValueForum members in posts. Learn more about guest access, and benefits of membership -- we hope you will consider joining ValueForum or trying out our service with a 24 hour trial pass.

• Latest LJPC SEC Filings

Filings Format Description Filed/Effective File/Film Number
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0000920465-17-000083 Size: 5 KB
2017-12-13
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0000920465-17-000082 Size: 5 KB
2017-12-13
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0000920465-17-000081 Size: 5 KB
2017-12-13
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0000920465-17-000080 Size: 5 KB
2017-12-13
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0000920465-17-000079 Size: 5 KB
2017-12-13
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0000920465-17-000078 Size: 5 KB
2017-12-13
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0000920465-17-000077 Size: 5 KB
2017-12-13
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0000920465-17-000076 Size: 5 KB
2017-12-13
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001209191-17-065526 Size: 5 KB
2017-12-13
EFFECT  Documents Notice of Effectiveness
Acc-no: 9999999995-17-003044 (33 Act)  Size: 1 KB
2017-11-21 16:00:00 333-221198
171218291
More LJPC SEC Filings


Related news from
Mon, 11 Dec 2017
13:10:00 +0000
Today’s Research Reports on Stocks to Watch: Soleno Therapeutics and La Jolla Pharmaceutical Company
NEW YORK, NY / ACCESSWIRE / December 11, 2017 / Soleno Therapeutics headed higher on Friday after its wholly-owned subsidiary Capnia Inc. entered into a joint venture with OptAsia Healthcare Limited of ...
Fri, 08 Dec 2017
18:54:00 +0000
Here's What's Causing Investors to Sell La Jolla Pharmaceutical Shares Today
The company's making progress toward an FDA decision on its lead drug candidate, but that's not enough to keep investors happy.
Mon, 04 Dec 2017
14:00:00 +0000
La Jolla Pharmaceutical Company Announces Initiation of Pivotal Clinical Study of LJPC‑401 in Patients with Beta Thalassemia
SAN DIEGO, Dec. 04, 2017-- La Jolla Pharmaceutical Company today announced the initiation of a pivotal clinical study of LJPC‑ 401 in patients with transfusion-dependent beta thalassemia who, despite chelation ...
Mon, 20 Nov 2017
12:57:26 +0000
La Jolla Pharmaceutical Co. breached its 50 day moving average in a Bearish Manner : LJPC-US : November 20, 2017
Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for La Jolla Pharmaceutical Co.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average ... Read more <b>(Read more...)</b>
Wed, 08 Nov 2017
18:43:53 +0000
La Jolla Pharmaceutical Co. breached its 50 day moving average in a Bullish Manner : LJPC-US : November 8, 2017
Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for La Jolla Pharmaceutical Co.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average ... Read more <b>(Read more...)</b>
Mon, 30 Oct 2017
07:00:00 +0000
La Jolla Pharmaceutical Earns Relative Strength Rating Upgrade
La Jolla Pharmaceutical shows improving price performance, earning an upgrade to its IBD Relative Strength Rating.
Thu, 26 Oct 2017
21:19:42 +0000
La Jolla Pharmaceutical posts 3Q loss
The San Diego-based company said it had a loss of $1.19 per share. The results exceeded Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss ...
Thu, 26 Oct 2017
21:10:00 +0000
La Jolla Pharmaceutical Company Announces Financial Results for the Three and Nine Months Ended September 30, 2017 and Recent Corporate Progress
La Jolla Pharmaceutical Company , a leader in the development of innovative therapies intended to significantly improve outcomes in patients suffering from life-threatening diseases, today reported financial results for the three and nine months ended September 30, 2017 and highlighted recent corporate progress.
Thu, 26 Oct 2017
15:07:12 +0000
La Jolla Pharmaceutical Co. – Value Analysis (NASDAQ:LJPC) : October 26, 2017
Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives La Jolla Pharmaceutical Co. a score of 25. Our analysis is based on comparing La Jolla Pharmaceutical Co. with the following peers – Repligen Corporation, Vical Incorporated, CEL-SCI Corporation, Intercept Pharmaceuticals, Inc., Amgen Inc., BioCryst Pharmaceuticals, Inc. and Titan Pharmaceuticals, Inc. (RGEN-US, VICL-US, CVM-US, ICPT-US, AMGN-US, BCRX-US ... Read more <b>(Read more...)</b>
Wed, 25 Oct 2017
12:15:13 +0000
La Jolla Pharmaceutical Co. breached its 50 day moving average in a Bearish Manner : LJPC-US : October 25, 2017
Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for La Jolla Pharmaceutical Co.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average ... Read more <b>(Read more...)</b>
Wed, 27 Sep 2017
11:30:00 +0000
Featured Company News - La Jolla Pharma Announces Intent to Submit MAA for LJPC-501, or Angiotensin II
LONDON, UK / ACCESSWIRE / September 27, 2017 / Pro-Trader Daily looks at the latest corporate events and news making the headlines for La Jolla Pharmaceutical Co. (NASDAQ: LJPC ) ("La Jolla"), ...
Mon, 25 Sep 2017
10:30:00 +0000
La Jolla Pharmaceutical Company Announces Intent to Submit Marketing Authorization Application for LJPC-501 in the Third Quarter of 2018
La Jolla Pharmaceutical Company today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use has issued favorable Scientific Advice regarding the EU regulatory pathway for LJPC-501 for the treatment of hypotension in adults with distributive or vasodilatory shock who remain hypotensive despite fluid and vasopressor therapy.
Wed, 20 Sep 2017
20:50:00 +0000
Prespecified Analysis of ATHOS-3 Indicates Survival Benefit in LJPC-501-Treated Patients with Relatively Low Angiotensin II State
La Jolla Pharmaceutical Company today announced an abstract entitled "Baseline angiotensin levels and ACE effects in patients with vasodilatory shock treated with angiotensin II" has been selected for presentation at the upcoming 30th European Society of Intensive Care Medicine LIVES Annual Congress being held September 23 to 27, 2017 in Vienna, Austria.
Fri, 15 Sep 2017
13:44:44 +0000
La Jolla Pharmaceutical Co. breached its 50 day moving average in a Bearish Manner : LJPC-US : September 15, 2017
Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for La Jolla Pharmaceutical Co.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average ... Read more <b>(Read more...)</b>
Mon, 28 Aug 2017
13:00:00 +0000
La Jolla Pharmaceutical Company Announces U.S. FDA Acceptance of New Drug Application for LJPC-501
La Jolla Pharmaceutical Company today announced that the U.S. Food and Drug Administration  has accepted for review the Company’s New Drug Application for the investigational drug LJPC-501 for the treatment of hypotension in adults with distributive or vasodilatory shock who remain hypotensive despite fluid and vasopressor therapy.
Fri, 25 Aug 2017
12:39:06 +0000
La Jolla Pharmaceutical Co. breached its 50 day moving average in a Bullish Manner : LJPC-US : August 25, 2017
Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for La Jolla Pharmaceutical Co.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average ... Read more <b>(Read more...)</b>
Thu, 24 Aug 2017
11:50:00 +0000
Corporate News Blog - Insys Therapeutics Releases Statement on Illinois Settlement; Provides Data against the Opioid-Induced Calamity in the US
Research Desk Line-up: La Jolla Pharma Post Earnings Coverage LONDON, UK / ACCESSWIRE / August 24, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for ...
Mon, 14 Aug 2017
21:58:53 +0000
La Jolla Pharmaceutical Co. – Value Analysis (NASDAQ:LJPC) : August 14, 2017
Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives La Jolla Pharmaceutical Co. a score of 25. Our analysis is based on comparing La Jolla Pharmaceutical Co. with the following peers – Repligen Corporation, Vical Incorporated, BioCryst Pharmaceuticals, Inc., Intercept Pharmaceuticals, Inc., CEL-SCI Corporation, Titan Pharmaceuticals, Inc. and Amgen Inc. (RGEN-US, VICL-US, BCRX-US, ICPT-US, CVM-US, TTNP-US ... Read more <b>(Read more...)</b>
Fri, 11 Aug 2017
14:09:47 +0000
La Jolla Pharmaceutical Co. breached its 50 day moving average in a Bearish Manner : LJPC-US : August 11, 2017
Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for La Jolla Pharmaceutical Co.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average ... Read more <b>(Read more...)</b>
Tue, 08 Aug 2017
13:00:00 +0000
La Jolla Pharmaceutical Company Announces Launch of Expanded Access Program for LJPC-501
La Jolla Pharmaceutical Company , today announced that the Company has initiated an expanded access program in the United States to provide its investigational drug, LJPC-501 , to patients with vasodilatory or distributive shock who cannot achieve target mean arterial pressure despite adequate fluid resuscitation and treatment with currently available vasopressors ).



"ValueForum is an active, private, online discussion community for stock & bond market investing. In discussion forums divided into finely grained topics, you will find sophisticated investors trading tips, research, and due diligence on value stocks, income investments, forex, market news, and more. Join in - trade ideas, strategies, current news, via our unique message bulletin boards, stock ratings system, and other online tools specifically geared toward our community."

Random member testimonial: "This is one of the brightest and most generous groups you will ever come across. While I firmly believe everyone has something to contribute to the collective wisdom, this is pretty much a left-brain group. Facts, evidence, and reasoned argument will earn you respect, even if some disagree with you." more testimonials »

Email / About | Privacy | Terms of Use | How To / FAQ | Msg Ticker | VF Home | My.vf | BDCs.vf | Energy.vf | REITs.vf | TA.vf
 
Nothing in ValueForum.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by ValueForum.com. ©2003 - 2017, Powered in part by Ticker TechnologiesContact Us

Stock Market Investing Forum - Trading Tips & Research - Online Message Boards